Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® Technology. Click here to start the conversation now.
Learn More
When to Launch an LDT: Key Factors to Consider
According to an MLO article, cost is just one element in a complex decision
A new article in Medical Laboratory Observer offers a practical look at the factors to consider when deciding whether to design a new laboratory-developed test or choose a send-out reference lab test or an in vitro diagnostic.
Continue Reading >
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Watch more videos >
May 7
Luminex Corporation Reports First Quarter 2018 Financial Results
April 16
Luminex Corporation First Quarter Earnings Release Scheduled for May 7, 2018
March 8
Luminex Corporation to Present at the Barclays Global Healthcare Conference
February 12
Luminex Corporation Reports Fourth Quarter and Full-Year 2017 Financial Results
February 6
Luminex Corporation To Present At LEERINK Partners 7th Annual Global Healthcare Conference
ESPID
May 28 – June 2
Malmo, Sweden
APHL Annual Meeting
June 2-4
Pasadena, CA
PSI Annual Meeting
June 3-6
Beurs Van Berlage, Amsterdam
ASM Microbe 2018
June 7-11
Atlanta, GA
Drug Discovery Summit
June 7-8
Berlin, Germany
